Английская Википедия:Hongming Chen
Шаблон:Short description Шаблон:Distinguish Hongming Chen is an American chemical engineer.
Chen earned a Bachelor's of Science degree in chemical engineering from the University of Texas at Austin in 1992, and completed a Master's and Doctor of Science in the same subject at the Massachusetts Institute of Technology. She then conducted research at Merck & Co. and AstraZeneca. She later helped establish TransForm Pharmaceuticals, which was later acquired by Johnson & Johnson, and subsequently worked for Kala Pharmaceuticals from its founding in 2010, then cofounded Metis Therapeutics.[1]
In 2015, Chen was elected a fellow of the American Institute for Medical and Biological Engineering.[2][3] She was elected to membership of the United States National Academy of Engineering in 2018.[4]
References
Шаблон:US-chemist-stub
Шаблон:US-engineer-stub
- Английская Википедия
- Living people
- Year of birth missing (living people)
- 21st-century American engineers
- 20th-century American engineers
- American women engineers
- American chemical engineers
- Massachusetts Institute of Technology alumni
- University of Texas at Austin alumni
- Members of the United States National Academy of Engineering
- Fellows of the American Institute for Medical and Biological Engineering
- AstraZeneca people
- Merck & Co. people
- Janssen Pharmaceutica people
- Страницы, где используется шаблон "Навигационная таблица/Телепорт"
- Страницы с телепортом
- Википедия
- Статья из Википедии
- Статья из Английской Википедии
